Cyclic peptide compositions for treatment of sexual dysfunction
US7897721B2 · kind B2 · utility
5Cited by
20References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2009 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Jan 5, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cyclic peptide of the structural formula:or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, m and p are as defined. Further provided are compositions for treatment of sexual dysfunction in mammals, including male sexual dysfunction, such as erectile dysfunction, and female sexual dysfunction, by administration of a cyclic peptide including a C-terminus —OH group. Routes of administration include injection, oral, urethral, vaginal, nasal and mucosal administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.